INSIGHTS ON CLINICAL TRIAL DESIGN
-
Navigating Tension Of Clinical Equipoise In Precision Oncology Trials
This roundtable discussion examines the tension between legacy methods and modern innovation, exploring the complexities of hybrid trial designs and the changing regulatory landscape.
-
Helping Biotechs Overcome 4 Key Challenges
Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
-
Speed Kills: When Timelines Trump Science In Neuropsychiatric Trials
This Bold Conversation brings together experts helping to define the next chapter of psychedelic clinical research to unpack lessons from recent regulatory reviews and explore what clinical teams need now.
-
Building Recruitment Into Early-Phase Trial Design
Successful recruitment starts with smart study design. Early recruitment insight improves feasibility, supports realistic timelines, and reduces enrollment risk.
-
Make Trial Participation Easier With An Innovative Technology Platform5/14/2025
Explore an impactful, innovative solution aimed at making patient participation in clinical trials easier.
-
Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells Us9/22/2026
Controlled immune challenges link drug exposure to biological effects, helping refine dose selection, test mechanisms and support better decisions before patient trials.
-
Choosing The Most Effective Method For Biopharmaceutical Development5/2/2025
Explore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.
-
Are Your Clinical Study Meetings Building Momentum, Or Wasting Time?9/17/2025
Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.
-
Strategic CMC Considerations For Pre-IND Meetings: Setting The Stage For A Successful TPP9/1/2025
In biotechnology, the Pre-Investigational New Drug (Pre-IND) stage is a critical juncture. Explore the pivotal role of Chemistry, Manufacturing, and Controls (CMC) in navigating this phase.
CLINICAL TRIAL DESIGN SOLUTIONS
-
The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.
-
TrialScope Disclose delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.
-
CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
-
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.